European Primary Care Cardiovascular Society

Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation

3' education - Jan. 2, 2024 - Jeff Healey, MD - Hamilton, ON, Canada

Educational information

This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.


Jeff Healey, MD is Professor of Medicine at McMaster University in Hamilton, ON, Canada.


This recording was developed under auspices of EPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of EPCCS.

Read a summary of the ARTESIA trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: